What are the opening hours?

Monday 8am - 6pm Tuesday 8am - 6pm Wednesday 8am - 6pm Thursday 8am - 6pm Friday 8am - 6pm Saturday 8am - 6pm

Baylor Genetics

Home
United States
Houston, TX
Baylor Genetics

Baylor Genetics is a joint venture of H.U. Group Holdings and the #1 NIH-funded genetics program at

Baylor Genetics is founded in academics and driven by discovery; we are dedicated to delivering comprehensive answers to the toughest genetic questions.

02/28/2026

More than 300 million people worldwide are living with a rare disease. Behind every number is a story shaped by uncertainty, resilience, and the search for answers.

For families like Kelly’s, that search can be long and complex. When traditional testing fell short, a combined Whole Genome Sequencing and RNA Sequencing approach at Baylor Genetics helped identify a FOXP4 variant linked to neurodevelopmental disorders, providing the clarity needed to guide her son Reed’s care.

Rare disease isn’t just a statistic. Families are navigating the unknown every day, while providers and researchers work tirelessly to close the diagnostic gap.

This Rare Disease Day, we’re reminded why this work matters. Learn more about Kelly and her family’s journey here: https://www.linkedin.com/pulse/mothers-strength-navigating-rare-disease-finding-answers-rjvre

02/25/2026

Precision diagnostics has the power to fundamentally change the patient odyssey—but only when innovation is designed to scale with purpose.

In a new Fast Company byline, Kengo Takishima, Chairman and CEO of Baylor Genetics, explores how genomic sequencing can shorten the diagnostic odyssey, enable more personalized care, and improve patient outcomes—and why realizing this potential requires more than technology alone.

Behind every test is a patient and a family seeking clarity, and behind every breakthrough is the operational excellence required to deliver answers accurately, efficiently, and at scale.

Read the full byline to learn how collaboration, data‑driven innovation, and patient‑centered design are shaping the future of precision diagnostics: https://www.fastcompany.com/91498078/how-to-scale-genomics-to-transform-precision-diagnostics

02/20/2026

Baylor Genetics is seeking a Director, Product Management, Clinical Diagnostic Genomics to lead the strategic direction and lifecycle ex*****on of our clinical genetic test portfolio.

In this role, you’ll oversee products from intake and launch to ensure clinical relevance, operational scalability, financial performance, and regulatory compliance. Partnering cross-functionally, you’ll translate enterprise strategy into clear, actionable portfolio roadmaps that drive disciplined ex*****on across the organization.

Join us in advancing the future of clinical diagnostic genomics and apply today: https://recruiting2.ultipro.com/BAY1006BML/JobBoard/0669eed3-5441-4f8e-a7b1-c5df596a4dfe/OpportunityDetail?opportunityId=ba6290bc-23e9-49ce-97ae-ce020eda0a6d

02/19/2026

In this video, Sydney Lau, MS, CGC and Leah Campbell, MS, CGC highlight how our RNA Sequencing test (RNA‑Seq) helped reclassify a variant of uncertain significance—providing the functional evidence needed to reach a diagnosis for a patient and his sister with a rare and complex condition.

When combined with our Whole Genome and Whole Exome Sequencing tests, RNA‑Seq can help support variant interpretation when DNA‑based testing alone may not tell the full story.

Learn more: https://www.baylorgenetics.com/rna-sequencing/

02/18/2026

Rare diseases are complex, but uncovering answers doesn’t have to be. For many patients and families, the diagnostic odyssey can span years, carry significant cost, and create ongoing uncertainty.

At Baylor Genetics, our multimodal approach begins with Whole Genome Sequencing (WGS) to detect variants across more than 20,000 genes, helping uncover potential explanations for a patient’s symptoms. This comprehensive view allows us to evaluate multiple variant types, generate meaningful insights, and determine when deeper analysis may help move closer to a diagnosis.

Learn how WGS can help bring clarity for your patients: https://www.baylorgenetics.com/whole-genome-sequencing/

02/17/2026

Happy Lunar New Year from Baylor Genetics! 2026 is the Year of the Fire Horse, a symbol of energy, independence, and forward momentum.

As we begin the year ahead, we wish you the freedom to innovate, the confidence to move boldly forward, and the momentum to make a lasting impact for providers, patients and families everywhere.

02/13/2026

Baylor Genetics is seeking a Technical Product Manager of EMR Interoperability to drive the development of reliable, scalable, and compliant integrations that enable seamless ordering, results delivery, and data exchange across healthcare systems.

In this role, you will own EMR integration backlogs, define API and data requirements, and deliver high-quality interoperability solutions, including Epic Aura. Your technical leadership will help ensure our digital ecosystem efficiently supports clinicians, labs, and patients at scale.

Apply now: https://recruiting2.ultipro.com/BAY1006BML/JobBoard/0669eed3-5441-4f8e-a7b1-c5df596a4dfe/OpportunityDetail?opportunityId=839b3ab2-20cf-4d02-abca-a671f01fb7bf

02/11/2026

For patients needing answers fast, genomic sequencing should be the first step, not a last resort.

At Baylor Genetics, helping clinicians unlock answers sooner—supporting faster, more informed clinical care—is at the heart of what we do. We take a multiomic approach that begins with our Whole Genome and Whole Exome Sequencing, combined with technologies such as RNA‑Seq to uncover answers earlier, even in the most rare and complex cases.

Learn how Baylor Genetics can help shorten the diagnostic odyssey: www.baylorgenetics.com

02/06/2026

Baylor Genetics is seeking a Director of Product Lifecycle Management to lead the strategic and operational management of our clinical genetic test portfolio across its lifecycle.

In this role, you will partner cross-functionally and lead the lifecycle strategy for our clinical test portfolio to turn enterprise priorities into clear roadmaps, and guide Product Managers in driving data-informed, compliant product decisions.

Join us in building the future of precision diagnostics. Apply now: https://recruiting2.ultipro.com/BAY1006BML/JobBoard/0669eed3-5441-4f8e-a7b1-c5df596a4dfe/OpportunityDetail?opportunityId=ba6290bc-23e9-49ce-97ae-ce020eda0a6d

02/05/2026

Our Global MAPS® test can transform how providers approach patient diagnosis by expanding beyond standard metabolic testing. By analyzing hundreds of metabolites in a single assay, Global MAPS® provides functional insights that can reveal answers, especially when genomic findings alone are inconclusive.

When combined with Whole Genome or Whole Exome Sequencing, Global MAPS® delivers a more complete biological picture that supports confident interpretation and earlier, more informed clinical decision‑making.

Learn more about how Baylor Genetics helps improve outcomes for patients and families through our multiomic approach to care: www.baylorgenetics.com

02/04/2026

At Baylor Genetics, we help providers translate complex genomic insights into clear, confident clinical decisions—faster.

We asked Emily Strait, Senior Director of Diagnostic Genomics at Baylor Genetics, where she sees our greatest opportunity in 2026, from establishing precision diagnostics as the standard of care to expanding access and building systems that support earlier intervention.

Learn more about how Baylor Genetics can help you deliver clearer answers when patients need them most: www.baylorgenetics.com

02/03/2026

This Black History Month, we honor the lasting impact Black scientists, clinicians, and leaders have made, and continue to make, across genetics, genomics, and healthcare innovation.

Through groundbreaking research and visionary leadership, they are expanding our understanding of human biology and helping shape a more equitable, personalized future for healthcare.

Genomics is stronger because of their dedication, excellence, and commitment to pushing the boundaries of scientific discovery.

Address

2450 Holcombe Boulevard
Houston, TX
77021

Opening Hours

Monday	8am - 6pm
Tuesday	8am - 6pm
Wednesday	8am - 6pm
Thursday	8am - 6pm
Friday	8am - 6pm
Saturday	8am - 6pm

Telephone

+18004114363

Website

https://baylorgenetics.com/

Alerts

Be the first to know and let us send you an email when Baylor Genetics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Psych Dimensions
Clinica Hispana Shotwell
723 Shotwell Street Suite B

Our Story

Baylor Genetics is a joint venture of Miraca Holdings, Inc. and Baylor College of Medicine, including the #1 NIH-funded Department of Molecular and Human Genetics. A pioneer of precision medicine for nearly 40 years, Baylor Genetics now offers a full spectrum of clinically relevant genetic testing, access to world-renowned experts, and the confidence to provide patients with the best care.

Baylor Genetics, located in Houston’s Texas Medical Center, serves clients in 50 states and 16 countries.